BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/24/2016 2:38:00 PM | Browse: 985 | Download: 1091
Publication Name World Journal of Immunology
Manuscript ID 29766
Country United Kingdom
Received
2016-08-27 13:52
Peer-Review Started
2016-08-29 15:00
To Make the First Decision
2016-09-27 17:25
Return for Revision
2016-10-08 20:56
Revised
2016-10-16 19:09
Second Decision
2016-10-21 18:32
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2016-10-27 17:11
Articles in Press
2016-10-27 17:11
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2016-11-21 08:48
Publish the Manuscript Online
2016-11-24 14:38
ISSN 2219-2824 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Immunology
Manuscript Type Editorial
Article Title Myeloid derived suppressor cells in breast cancer: A novel therapeutic target?
Manuscript Source Invited Manuscript
All Author List Rebekah M Weston and Cordula M Stover
Funding Agency and Grant Number
Corresponding Author Cordula M Stover, PhD, Associate Professor, Department of Infection, Immunity and Inflammation, University of Leicester, Maurice Shock Medical Sciences Building, University Road, Leicester LE1 9HN, United Kingdom. cms13@le.ac.uk
Key Words Breast cancer; Immune cells; Treatment; Suppression; Survival
Core Tip Breast cancer is the most common cancer among women in the United Kingdom; there were 44540 new cases of invasive carcinoma in 2013. The incidence rate is 169.8:100000, an increase of 5.5% in 10 years. Despite significant advances in the detection and treatment of breast cancer, breast cancer still results in 11600 deaths a year; the second highest number of cancer deaths in women. With increased appreciation of the sustaining importance of cells in the tumour microenvironment, in particular myeloid derived suppressor cells, their targeting is being considered as a novel treatment approach.
Publish Date 2016-11-24 14:38
Citation Weston RM, Stover CM. Myeloid derived suppressor cells in breast cancer: A novel therapeutic target? World J Immunol 2015; 6(3): 119-125
URL http://www.wjgnet.com/2219-2824/full/v6/i3/119.htm
DOI http://dx.doi.org/10.5411/wji.v6.i3.119
Full Article (PDF) WJI-6-119.pdf
Full Article (Word) WJI-6-119.doc
Manuscript File 29766-Review.docx
Answering Reviewers 29766-Answering reviewers.pdf
Audio Core Tip 29766-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 29766-Conflict-of-interest statement.pdf
Copyright License Agreement 29766-Copyright assignment.pdf
Peer-review Report 29766-Peer-review(s).pdf
Scientific Misconduct Check 29766-Scientific misconduct check.pdf
Scientific Editor Work List 29766-Scientific editor work list.pdf